BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31499430)

  • 1. UPLC-MS/MS method for the determination of talazoparib in rat plasma and its pharmacokinetic study.
    Ye L; Chen J; Li SL; Zhu YL; Xie S; Du X
    J Pharm Biomed Anal; 2020 Jan; 177():112850. PubMed ID: 31499430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-tandem mass spectrometric method for the quantification of eliglustat in rat plasma and the application in a pre-clinical study.
    Chen J; Shao Y; Zhu H; Chen X; Ye X
    J Pharm Biomed Anal; 2020 Jan; 177():112858. PubMed ID: 31518862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method for the determination of Bosutinib in rat plasma by UPLC-MS/MS.
    Xu Y; Huang XC; Dai S; Xiao Y; Zhou MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1004():93-7. PubMed ID: 26454795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of Guanfu base G and its active metabolites by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
    Zhang L; Wang A; Wang X; Zhang Y; Li X; Liu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():1-6. PubMed ID: 24636893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid determination of ruscogenin in rat plasma with application to pharmacokinetic study.
    Ji PY; Li ZW; Yang Q; Wu R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():71-4. PubMed ID: 25660717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of liensinine in rat plasma using ultra-performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.
    Lv SF; Wang XH; Li HW; Zhang XL; Wang B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 992():43-6. PubMed ID: 25939097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel and quick UPLC-MS/MS method for the pharmacokinetic analysis of duvelisib in beagle dogs.
    Shao Y; Xie S; Zhu H; Du X; Xu RA
    J Pharm Biomed Anal; 2020 Aug; 187():113355. PubMed ID: 32442869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of cephalomannine in rat plasma by gradient elution UPLC-MS/MS method.
    Wang XS; Sun JC; Yang RN; Ren J; Liang S; Sun M; Wang YF; Gao SG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():70-4. PubMed ID: 24929960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.
    Shi X; Zhu D; Lou J; Zhu B; Hu AR; Gan D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():353-7. PubMed ID: 26363369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of tivantinib in rat plasma using ultra performance liquid chromatography with tandem mass spectrometry.
    Bai YL; Yuan HC; Zhang DT; Liu Y; Zhang Y
    J Pharm Biomed Anal; 2016 Jul; 126():98-102. PubMed ID: 27179187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS.
    Sun W; Jiang ZL; Zhou L; Chen RM; Wang Z; Li WS; Jiang SM; Hu GX; Chen RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():14-8. PubMed ID: 25596380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study.
    Huang Y; Zheng S; Pan Y; Li T; Xu ZS; Shao MM
    J Pharm Biomed Anal; 2016 Sep; 128():184-190. PubMed ID: 27262994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validated UPLC/MS/MS assay for quantitative bioanalysis of elbasvir in rat plasma and application to pharmacokinetic study.
    Liu H; Xu H; Song W; Zhang Y; Yu S; Huang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():150-156. PubMed ID: 26927874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of obeticholic acid in rat plasma and its application in preclinical pharmacokinetic studies.
    Li XY; Zhu SH; Yang F; Hu GX; Yuan LJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():82-88. PubMed ID: 31129439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of acacetin in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Fan LH; Li X; Chen DY; Zhang N; Wang Y; Shan Y; Hu Y; Xu RA; Jin J; Ge RS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():18-22. PubMed ID: 25703948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantification and pharmacokinetic investigation of selexipag and its main metabolite ACT-333679 in rat plasma by UPLC-MS/MS method.
    Xie S; Shi L; Chen J; Xu RA; Ye X
    J Pharm Biomed Anal; 2020 Oct; 190():113496. PubMed ID: 32768890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLC-MS/MS determination and gender-related pharmacokinetic study of five active ingredients in rat plasma after oral administration of Eucommia cortex extract.
    Hu F; An J; Li W; Zhang Z; Chen W; Wang C; Wang Z
    J Ethnopharmacol; 2015 Jul; 169():145-55. PubMed ID: 25910535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPLC-MS/MS method for determination of avicularin in rat plasma and its application to a pharmacokinetic study.
    Zhang WM; Li RF; Sun M; Hu DM; Qiu JF; Yan YH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():107-11. PubMed ID: 25010713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of nintedanib and its metabolite by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
    Lin D; Qiao LM; Zhang YN; Liu Y; Liu XS
    J Pharm Biomed Anal; 2016 Jan; 117():173-7. PubMed ID: 26355771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetic profiles of selected irreversible tyrosine kinase inhibitors, neratinib and pelitinib, with apigenin in rat plasma by UPLC-MS/MS.
    Maher HM; Alzoman NZ; Shehata SM; Abahussain AO
    J Pharm Biomed Anal; 2017 Apr; 137():258-267. PubMed ID: 28167419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.